These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16607602)

  • 1. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
    Heusch G; Schulz R
    Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.
    Healey JS; Morillo CA; Connolly SJ
    Curr Opin Cardiol; 2005 Jan; 20(1):31-7. PubMed ID: 15596957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials, the renin angiotensin system and atrial fibrillation.
    Birnie DH; Gollob M; Healey JS
    Curr Opin Cardiol; 2006 Jul; 21(4):368-75. PubMed ID: 16755207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in atrial fibrillation.
    Levine MJ; Schweitzer P
    Vnitr Lek; 2010 Nov; 56(11):1138-41. PubMed ID: 21247007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation].
    Doğan A; Akçay S
    Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R; Szwed H
    Kardiol Pol; 2007 Apr; 65(4):440-5. PubMed ID: 17530565
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.
    Anand K; Mooss AN; Hee TT; Mohiuddin SM
    Am Heart J; 2006 Aug; 152(2):217-22. PubMed ID: 16875900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications.
    Lévy S
    Nat Clin Pract Cardiovasc Med; 2006 Apr; 3(4):220-5. PubMed ID: 16568131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of suppressing the renin-angiotensin system on atrial fibrillation.
    Kalus JS; Coleman CI; White CM
    J Clin Pharmacol; 2006 Jan; 46(1):21-8. PubMed ID: 16397280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficiency of renin-angiotensin inhibitors in preventing atrial fibrillation in patients with a normal heart.
    Fazio G; Pizzuto C; Sutera L; Guttilla D; Di Gesaro G; Cascio C; Novo G; Assennato P; Novo S
    Minerva Cardioangiol; 2007 Jun; 55(3):311-5. PubMed ID: 17534249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.
    Boos CJ; Lip GY
    J Hum Hypertens; 2005 Nov; 19(11):855-9. PubMed ID: 16094406
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of the renin-angiotensin system for prevention of atrial fibrillation.
    Zografos T; Katritsis DG
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1270-85. PubMed ID: 20636314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation and renin-angiotensin system].
    Yamashita T
    Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
    Ducharme A; Schiffrin EL
    Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation and renin-angiotensin-aldosterone system: believe it or not.
    Fauchier L; de Groote P
    Europace; 2011 Mar; 13(3):297-8. PubMed ID: 21217131
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY; Frison L; Grind M
    J Intern Med; 2007 Jun; 261(6):577-86. PubMed ID: 17547713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.